Rebeca Rivera
Nurse Practitioner · Avon Park, FLNPI 1184113094
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,862, 7.6 times the $244 reported in 2021. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $30.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$656
- AstraZeneca$469
- Novo Nordisk$380
- Bayer$324
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$226
- Axsome Therapeutics, Inc.$202
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,649100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 18 | $656 |
| AstraZeneca | 9 | $469 |
| Novo Nordisk | 14 | $380 |
| Bayer | 9 | $324 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $226 |
| Axsome Therapeutics, Inc. | 7 | $202 |
| Exact Sciences | 10 | $187 |
| Lilly USA, LLC | 8 | $144 |
| Dexcom, Inc. | 3 | $140 |
| Abbott | 6 | $134 |
| Intuitive Surgical | 1 | $103 |
| Amgen | 4 | $87 |
| Paratek Pharmaceuticals, Inc. | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 2 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| Novartis | 2 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| MVP Orthopedics Inc | 1 | $43 |
| Pfizer | 2 | $38 |
| Ascensia Diabetes Care US Inc. | 1 | $35 |
| GSK | 1 | $35 |
| Cequr Corporation | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Merck | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,649 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 99 | $132,607 |
| EliquisApixaban | 36 | $51,005 |
| JardianceEmpagliflozin | 35 | $47,302 |
| OzempicSemaglutide | 36 | $45,380 |
| RybelsusSemaglutide | 19 | $29,994 |
| TrulicityDulaglutide | 26 | $26,714 |
| RexultiBrexpiprazole | 13 | $20,819 |
| FarxigaDapagliflozin Propanediol | 18 | $18,633 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $9,906 |
| Repatha SureclickEvolocumab | 12 | $9,057 |
| Praluent PenAlirocumab | 11 | $6,033 |
| Lidocaine | 25 | $5,072 |
| Advair HfaFluticasone Propion/Salmeterol | 14 | $4,613 |
| Gabapentin | 201 | $4,015 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $3,193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $144 | $159,321125 claims |
| Novo NordiskOzempic, Rybelsus | $380 | $75,37355 claims |
| PfizerEliquis, Paxlovid | $38 | $52,43447 claims |
| Boehringer IngelheimJardiance | $22 | $47,30235 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $28 | $20,81913 claims |
| AstraZenecaFarxiga | $469 | $18,63318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Avon Park
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.